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Inhibiting Infectivity of the
Spindle Shaped Virus using
Silver Nanoparticles
By Diana Demchenko, Dr. Ken Stedman, Dr. Marilyn
Mackiewicz, Julie Reed

1. To what extent do silver nanoparticles
inhibit the infectious ability of the
Spindle Shaped Virus?
2. What is the mode of inhibition?

Why should you care?

Figure: Mode of infection for viruses

Spindle Shaped Virus

Spindle Shaped Virus
-Have different structures and sequences from
the viruses we know now.
-Infect Sulfolobus, an extremely thermophilic
archaea
-Survive in low pH (below 4), and high
temperatures (80C=176F)
-Found in geothermally heated hot springs

Silver Nanoparticles
-Viewed using Transmission Electron
Microscopy.
-Ag+ is reduced to Ag0 using NaBH4 and a
ligand is added to stabilize the particle.
-Different from regular silver.
-A 10 nm particle is about 12,000 silver atoms
-Different shapes

Previous Studies
-A possible approach to drug-resistant
viruses.
-Antibacterial properties due to unique
physiochemical properties.
-A possible different approach to fight
viruses such as HIV, Hepatitis C, influenza,
etc.
-Shown to inhibit virus infectivity in vitro.
-Interact with sulfur-containing proteins
FIgure 1: a)AgNP-exposed HIV-1 virus (attached to glycoprotein
knobs)
b)HIV-1 virus not exposed to AgNP

Figure: Process of making plaques assays, nanoparticles were combined with the virus stock

How I tested Infectivity of the Spindle Shaped Virus

With Virus

Without Virus

Results (0 hours)
A)

B)

FIgure 2: a)Plaque assay with mixture of Wild Type and NPs at 10^3 (1,680,000 pfu/ml). b) Plaque assay with Wild
Type at 10^3 (TMTC)

Results (24 hours)
A)

B)

Figure 2: a) Wild type with AgNP at 10^4 (2*10^6 pfu/mL) b)Wild type at 10^4 (2.5*10^7 pfu/mL)

Results (72 hours)
A)

B)

Figure 3: a) Wild type and AgNP at 10^4 dilution (2.05*10^7 pfu/mL) b) Wild type only at 10^4 dilution (TMTC)

Results (96 hours)
A)

B)

Figure 4: a) Wild type with AgNP at 10^4 (3.6*10^6 pfu/mL) b) Wild type with no AgNP at 10 ^4 (1.3*10^7 pfu/mL)

Figure: Possible modes of inhibition of the silver nanoparticle.

NP attachment

Figure: Possible modes of inhibition for the Spindle Shaped Virus.

Conclusions
- Further studies in this area could open up new ways to fight drug-resistant
viruses.
-Different parameters could be tested: different shapes/types of AgNP, differing
concentrations of AgNP, different viruses, etc.
-Further testing with silver nanoparticles and other nanoparticles (such as gold),
could give us a different approach to viruses.

THANK YOU
Special thanks to Dr. Mackiewicz and Julie Reed for
collaborating, Dr. Stedman and David Goodman for being
great mentors, and BUILD EXITO for giving me the
opportunity to do research.

Sources Cited
1. Oldenburg, Steven J. "Silver Nanoparticles: Properties and Applications."
Sigma-Aldrich. N.p., n.d. Web. 06 Apr. 2017.
2. Elechiguerra, Jose Luis. Et al. Interaction of Silver Nanoparticles with HIV-1.
3. Rogers, James V. Et al. A Preliminary Assessment of Silver Nanoparticle Inhibition
of Monkeypox Virus Plaque Formation.
4. Speshock, Janice L. Et al. Interaction of Silver Nanoparticles with Tacaribe Virus.
5. Lu, Lei. Et al. Silver Nanoparticles Inhibit Hepatitis B Virus Replication.
6. N. Khandelwal , G. Kaur, N. Kumara , A. Tiwari. Application of Silver
Nanoparticles in Viral Inhibition: A New Hope for Antivirals.

